|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
See Header: Elevated prostate specific antigen [PSA]
ICD-10 (CM) Code and Descriptor
|
R97.21 |
Rising PSA following treatment for malignant neoplasm of prostate
Age 14 and up.
Diagnosis Valid for Male Patient Only
|
R9721 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 20.22%
|
36.77%
|
21.00%
|
9.74%
|
4.50%
|
2.59%
|
1.64%
|
1.17%
|
0.74%
|
0.47%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R97.21*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
84153
|
ASSAY OF PSA TOTAL |
3,180
|
3,180
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,818
|
2,827
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,034
|
2,036
|
|
78815
|
PET IMAGE W/CT SKULL-THIGH |
1,418
|
1,418
|
|
A9588
|
FLUCICLOVINE F-18 |
872
|
7,526
|
|
G1004
|
CDSM NDSC |
814
|
937
|
|
80053
|
COMPREHEN METABOLIC PANEL |
798
|
798
|
|
77385
|
NTSTY MODUL RAD TX DLVR SMPL |
760
|
760
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
689
|
689
|
|
84403
|
ASSAY OF TOTAL TESTOSTERONE |
673
|
673
|
|
78306
|
BONE IMAGING WHOLE BODY |
601
|
601
|
|
A9503
|
TC99M MEDRONATE |
503
|
503
|
|
A9515
|
CHOLINE C-11 |
427
|
427
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
399
|
38,400
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
336
|
336
|
|
82565
|
ASSAY OF CREATININE |
328
|
328
|
|
72197
|
MRI PELVIS W/O & W/DYE |
311
|
311
|
|
J9217
|
LEUPROLIDE ACETATE SUSPNSION |
273
|
1,054
|
|
96402
|
CHEMO HORMON ANTINEOPL SQ/IM |
270
|
271
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
268
|
268
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R97.21 related to the following DRG Codes:
947-948
|
